HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 20:00
HUTCHMED Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2021 | -61.25M |
March 31, 2021 | -41.14M |
June 30, 2020 | -33.55M |
March 31, 2020 | -16.14M |
June 30, 2019 | -25.48M |
March 31, 2019 | -19.88M |
Date | Value |
---|---|
June 30, 2018 | -20.96M |
March 31, 2018 | -11.73M |
December 31, 2015 | 3.359M |
September 30, 2015 | -11.32M |
December 31, 2014 | -2.865M |
September 30, 2014 | -10.89M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-61.25M
Minimum
Jun 2021
-16.14M
Maximum
Mar 2020
-38.02M
Average
-37.35M
Median
Net Income (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 619.69M |
AstraZeneca PLC | 1.927B |
Sino Biopharmaceutical Ltd | -- |
Regencell Bioscience Holdings Ltd | -- |
Prenetics Global Ltd | -10.72M |
Net Income (Quarterly) Related Metrics
Enterprise Value | 2.171B |
Earnings Yield | -1.49% |
Normalized Earnings Yield | -1.493 |